{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Atypical haemolytic uraemic syndrome",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_eculizumab",
          "name": "Eculizumab"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_ravulizumab",
          "name": "Ravulizumab"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_c5_inhibitor",
          "name": "C5 Inhibitor"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_complement_inhibitor",
          "name": "Complement Inhibitor"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_atacicept",
          "name": "Atacicept"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_efgartigimod",
          "name": "Efgartigimod"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_ishmael",
          "name": "Ishmael"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_aixin",
          "name": "Aixin"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_c1_inhibitor",
          "name": "C1 Inhibitor"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_pandemic_influenza_vaccine",
          "name": "Pandemic Influenza Vaccine"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_anti_c5_monoclonal_antibody",
          "name": "Anti-C5 Monoclonal Antibody"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_lixisenatide",
          "name": "Lixisenatide"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_eculizumab",
          "type": "Drug",
          "label": "Eculizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ravulizumab",
          "type": "Drug",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_c5_inhibitor",
          "type": "Drug",
          "label": "C5 Inhibitor",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_complement_inhibitor",
          "type": "Drug",
          "label": "Complement Inhibitor",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_atacicept",
          "type": "Drug",
          "label": "Atacicept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_efgartigimod",
          "type": "Drug",
          "label": "Efgartigimod",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_ahtus",
          "type": "Disease",
          "label": "Atypical Haemolytic Uraemic Syndrome",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_eculizumab",
          "target": "disease_ahtus",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "已在临床上用于治疗该病"
        },
        {
          "source": "drug_ravulizumab",
          "target": "disease_ahtus",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "机制类似于 Eculizumab，临床应用潜力大"
        },
        {
          "source": "drug_c5_inhibitor",
          "target": "disease_ahtus",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "靶向相同通路的药物"
        },
        {
          "source": "drug_complement_inhibitor",
          "target": "disease_ahtus",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "用于调节补体系统，相关性强"
        },
        {
          "source": "drug_atacicept",
          "target": "disease_ahtus",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "在相关疾病中有潜在疗效"
        },
        {
          "source": "drug_efgartigimod",
          "target": "disease_ahtus",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "正在研究中作为潜在治疗"
        },
        {
          "source": "drug_eculizumab",
          "target": "drug_ravulizumab",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "同类药物机制相似"
        },
        {
          "source": "drug_c5_inhibitor",
          "target": "drug_complement_inhibitor",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "靶向补体系统的相似作用机制"
        }
      ]
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多种补体系统抑制剂可用于治疗 Atypical Haemolytic Uraemic Syndrome",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "所有药物在治疗中具有必要的药代动力学性质"
    ],
    "uncertainties": [
      "具体疗效与长期安全性需在临床研究中进一步验证"
    ],
    "next_focus_for_pi": [
      "进一步验证各药物对病理机制的具体影响及临床试验数据"
    ]
  }
}